Načítá se...
Addressing the needs of Canadians with rare diseases: an evaluation of orphan drug incentives
It is uncertain whether a Canadian orphan drug policy, similar to those used in the US and EU, will be given further consideration. The justification for having an orphan drug policy is initially discussed, with this article proceeding on the basis that morality and a commitment to equality validate...
Uloženo v:
| Vydáno v: | J Law Biosci |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534751/ https://ncbi.nlm.nih.gov/pubmed/31143457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jlb/lsy019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|